使用本网站需要启用 JavaScript, 请启用后刷新页面获得更好的体验
登录
注册
首页
个人基因检测
临床应用研究
科研合作项目
合作与服务
社区
研究所
微解读
应用
姓氏祖源
基因关系
原始数据
纯合片段
使用 WeGene 需要启用 Cookies, 请启用后刷新页面获得更好的体验
社区首页
小组
白癜风
白癜风
发起讨论
白癜风
7 个讨论
只看精华帖
按热门排序
按最新排序
更新后59.42倍还没得……
大木米
• 最后回复
WeChat_350223
•
2024-11-11 17:56
95
1
• 来自相关小组
15.73倍还没得……
大木米
• 最后回复
赵日天2
•
2018-11-24 22:37
2698
1
• 来自相关小组
0.57倍,还是得了……
Idany2000
• 最后回复
元月十号
•
2018-10-16 16:01
3564
6
• 来自相关小组
我0.64倍 还是患了白癜风
风流的12号染色体
• 最后回复
kaji
•
2018-10-16 14:36
3313
4
• 来自相关小组
我是6倍多,害怕。。。。
luna214
• 最后回复
元月十号
•
2018-07-03 10:26
2610
1
• 来自相关小组
我外婆有白癜风,我是1.41倍。
radimei
• 最后回复
紫菜莴苣
•
2018-05-21 15:53
3637
2
• 来自相关小组
发起讨论
白癜风
7 个讨论
相关基因
UBASH3A
位点:RS11203203
TYR
位点:RS1126809
位点:RS1393350
IRF4
位点:RS12203592
LPP
位点:RS13076312
SMOC2
位点:RS13208776
RNASET2
位点:RS2236313
C1QTNF6
位点:RS229527
BCL2L12
位点:RS2304206
PTPN22
位点:RS2476601
IFIH1
位点:RS3747517
HCG9
位点:RS3823355
RERE
位点:RS4908760
IL2RA
位点:RS706779
ARID5B
位点:RS71508903
TNFRSF11A
位点:RS8083511
GZMB
位点:RS8192917
RALY
位点:RS6059655
BACH2
位点:RS72928038
PTPRC
位点:RS16843742
FARP2
位点:RS41342147
CPVL
位点:RS117744081
TG
位点:RS2687812
CASP7
位点:RS12771452
SLC1A2
位点:RS1043101
PLCB3
位点:RS12421615
HERC2
位点:RS1635168
DEF8
位点:RS4268748
RAB5C
位点:RS11079035
TEF
位点:RS9611565
IL1RAPL1
位点:RS73456411
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8.
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
Validation of susceptibility loci for vitiligo identified by GWAS in the Chinese Han population
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants